Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.
about
Radiotherapy of Ductal Carcinoma In SituExtent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort studyEvaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer.A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast.Studies on DNA Damage Repair and Precision Radiotherapy for Breast Cancer.The Relationships between HER2 Overexpression and DCIS Characteristics.A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer.
P2860
Q26776277-5945A873-3747-4D84-820B-C1D3CAD38676Q37075615-8870A238-1A38-429F-8512-A1EBE968EE7FQ38429498-6FB5E5A3-194C-4D40-A91F-7473628370B3Q41395831-374B6141-8CBE-499F-B4CF-5CED60214C3CQ46699535-FC8EACDE-95DA-48E6-8824-3BEEAFAF3834Q47097148-85C9D3CB-279A-4B84-8BC9-BC63630789D6Q49544386-8AABEADB-26E6-4ADE-AEA1-B12BBE353E1EQ51016417-AC9DBB5C-7F4E-49F4-85CD-1F7D349FE87BQ55026796-1E1BDB28-B7BE-49D0-BF20-90CFD175EB81
P2860
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Risk of subsequent in situ and ...... tive ductal carcinoma in situ.
@en
Risk of subsequent in situ and ...... tive ductal carcinoma in situ.
@nl
type
label
Risk of subsequent in situ and ...... tive ductal carcinoma in situ.
@en
Risk of subsequent in situ and ...... tive ductal carcinoma in situ.
@nl
prefLabel
Risk of subsequent in situ and ...... tive ductal carcinoma in situ.
@en
Risk of subsequent in situ and ...... tive ductal carcinoma in situ.
@nl
P2093
P2860
P50
P356
P1433
P1476
Risk of subsequent in situ and ...... itive ductal carcinoma in situ
@en
P2093
A Esposito
A Goldhirsch
D Disalvatore
N Rotmensz
R Orecchia
P2860
P304
P356
10.1093/ANNONC/MDV013
P577
2015-01-18T00:00:00Z